Most Clicked StoriesMore >


Canagliflozin use associated with leg and foot amputations, FDA warns

DiabetesPro SmartBrief | May 20, 2016

Patients who use Invokana or Invokamet, Janssen's diabetes drugs that go by the generic name canagliflozin, could be two times more likely to have foot and leg amputations compared with a placebo group, the FDA warned in a safety alert. The alert is based on an ongoing clinical trial that found amputation rates for canagliflozin were seven per 1,000 patients at the 100 milligrams-per-day dose and five per 1,000 for the 300-milligram dose, but three per 1,000 for placebo. A second, similar study has not shown the same rates, and the FDA is still investigating if the drug increases amputation risk. Medscape (free registration) (05/18)


Type 1 diabetes tied to early loss of islet sympathetic nerves, study finds

DiabetesPro SmartBrief | May 23, 2016

Study looks at DKA incidence among diabetes patients after bariatric surgery

DiabetesPro SmartBrief | May 19, 2016

Novo Nordisk's diabetes drug obtains FDA panel support

DiabetesPro SmartBrief | May 25, 2016

Diabetes groups recommend gastric surgery as diabetes treatment

DiabetesPro SmartBrief | May 25, 2016

FDA grants expanded approval to Janssen's diabetes drug

DiabetesPro SmartBrief | May 25, 2016

Study links insulin resistance to NAFLD in diabetes

DiabetesPro SmartBrief | May 23, 2016

Nutrition label updated by FDA

DiabetesPro SmartBrief | May 23, 2016

Study: GDM, impaired insulin sensitivity tied to worse health outcomes

DiabetesPro SmartBrief | May 20, 2016

Study: Healthy lifestyle could prevent up to 40% of cancer cases

DiabetesPro SmartBrief | May 24, 2016


Find DiabetesPro SmartBrief Issues by Date:



ADA News More >


Call for Nominations: ADA 2017 Professional Interest Group Awards

DiabetesPro SmartBrief | May 26, 2016

Call for Nominations: ADA 2017 Outstanding Educator in Diabetes Award

DiabetesPro SmartBrief | May 25, 2016

Call for Nominations: ADA 2017 Harold Rifkin Award

DiabetesPro SmartBrief | May 24, 2016

Call for Nominations: ADA 2017 Outstanding Physician-Clinician Award

DiabetesPro SmartBrief | May 23, 2016

Call for Nominations: ADA 2017 Kelly West Award for Outstanding Achievement in Epidemiology

DiabetesPro SmartBrief | May 20, 2016




Sign up for DiabetesPro SmartBrief



Designed specifically for health care professionals, DiabetesPro SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news, trends, and technology updates that matter most to health care professionals. Learn more

Recent Poll view more polls


Poll: Do you think a glucose-sensing contact lens would be of benefit to your patients?

Chart.